Symposium 2
Symposium 5
JAS-TSLA-KSoLA Joint Symposium
Breakfast Symposium 2
AAS-KSoLA Joint Symposium
Plenary Lecture 1
Special Lecture 1
Luncheon Symposium 2
Symposium 14
Keynote Lecture 1
VAS-KSoLA Joint Symposium
Breakfast Symposium 6
CSATVB-KSoLA Joint Symposium
Plenary Lecture 2
Keynote Lecture 2
Luncheon Symposium 6
Special Lecture 2
KosFoST-KSoLA Joint Symposium
MSA-KSoLA Joint Symposium
09. 11(Thu)
09. 11(Thu) 13:00~14:30 Room 2
Cutting-edge Nutritional Approach for Cardiometaboic Risk Strategies
09. 11(Thu) 14:40~16:10 Room 2
TBD
09. 11(Thu) 16:20~17:50 Room 2
Familial Hypercholesterolemia (FH) in the Era of Precision Medicine
09. 12(Fri)
09. 12(Fri) 07:30~08:30 Room 2
09. 12(Fri) 08:30~10:00 Room 2
Comprehensive Strategies for the Prevention of Atherosclerosis: Current Insights and Future Directions
- Inflammation and atherosclerosis: emerging biomarkers and anti-inflammatory therapies 08:30~08:50
- The role of digital health technology in managing atherosclerosis: a new frontier 08:50~09:10
- Impact of lipid-lowering therapy on aortic aneurysm progression and cardiovascular outcomes 09:10~09:30
- Panel Discussion 09:30~10:00
09. 12(Fri) 10:20~11:00 Room 2
09. 12(Fri) 11:05~11:45 Room 2
09. 12(Fri) 13:00~14:30 Room 2
What is Important beyond Stenosis in Intracranial Atherosclerosis
09. 12(Fri) 15:50~16:30 Room 2
09. 12(Fri) 16:45~18:15 Room 2
Lipid-Lowering Strategies: Targets and Therapies in Clinical Practice
- Triglyceride and HDL-C focus in Asian populations: rethinking priorities? 16:45~17:05
- Combination lipid-lowering therapy: when statins alone are not enough 17:05~17:25
- Ethnic differences in managing dyslipidemia: tailoring treatment strategies for Asian and Western populations 17:25~17:45
- Panel Discussion 17:45~18:15
09. 13(Sat)
09. 13(Sat) 08:50~10:20 Room 2
Long-term Exposure to LDL-cholesterol and Early Cardiovascular Risk Prevention
09. 13(Sat) 10:40~11:20 Room 2
09. 13(Sat) 11:25~12:05 Room 2
09. 13(Sat) 13:30~14:40 Room 2
09. 13(Sat) 14:50~16:20 Room 2
Role of Medicinal Foods in Atherosclerosis and Cardiometabolic Disease
09. 13(Sat) 16:20~17:50 Room 2
Recent Evidence in Non-Invasive Cardiovascular Risk Assessment Techniques
